Director/Sr. Director, Health Economics & Outcomes Research Palo Alto, California, United State[...]
4 Days Old
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement… read on.
Scroll down the page to see all associated job requirements, and any responsibilities successful candidates can expect.
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you’re someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we’ll ask “why not?” and help reengineer the future of biopharma.
What You’ll Do BridgeBio is looking for a Director/Sr. Director, Health Economics & Outcomes Research, to join our strong and growing team. This position will report to the Head of Global Value & Health Economics. The role will focus on products in development and contribute to the conception and execution of innovative strategies to ensure patient access for all BridgeBio affiliate therapies and the evolving product pipeline portfolio. The candidate will provide insights to clinical trial development, clinical outcome assessments, and competitive assessments. The ideal candidate should be prepared to work in a fast-paced environment and collaborate with external stakeholders and cross-functionally with Market Access, Commercial Operations, Marketing, Clinical Development, Regulatory Affairs, and Strategic Planning.
Responsibilities Key Responsibilities in an Early HEOR Role:
Evidence Generation: Conduct literature reviews, data analysis, and modeling to generate HEOR evidence and insights. This may include analyzing clinical trial data, real-world evidence (RWE), and healthcare claims data.
Value Demonstration: Develop and disseminate HEOR reports, presentations, publications, and educational materials to support the value proposition of new drugs or therapies.
Work with cross-functional teams, including clinical development, market access, and medical affairs, to understand evidence needs and provide HEOR expertise.
HTA Support: Provide support for HTA submissions and processes, including dossier development and response to queries.
Develop cost-effectiveness models, budget impact analyses, and other HEOR models to assess the value of interventions.
Where You’ll Work This position will be expected to be on-site in both our San Francisco and Palo Alto offices on a weekly basis.
Who You Are Master’s degree in health economics or related discipline.
8+ years of relevant experience in health economics and outcomes research.
Experience in Rare Diseases and HEOR early-stage development activities and strategy. Muscular Dystrophy experience is preferred.
Global launch experience in a pharmaceutical company.
Proven track record of evidence synthesis (systematic literature review, indirect comparisons, etc.).
Proven track record of developing economic models (cost-effectiveness, budget impact).
Strong understanding of payer and HTA needs, and expertise in developing and delivering high-quality submissions.
Domestic and international travel required, expected to be 10-20% of the time and as needed.
Rewarding Those Who Make the Mission Possible We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return.
Market-leading compensation.
401K with 100% employer match on the first 3%, and 50% on the next 2%.
Employee stock purchase program.
Referral program with $2,500 award for hired referrals.
Comprehensive health care with 100% premiums covered – no cost to you and dependents.
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions).
Hybrid work model – employees have the autonomy in where and how they do their work.
Unlimited flexible paid time off – take the time that you need.
Paid parental leave – 4 months for birthing parents & 2 months for non-birthing parents.
Flex spending accounts & company-provided group term life & disability.
Subsidized lunch via Forkable on days worked from our office.
Skill Development & Career Paths:
Opportunities for skill development and internal mobility from discovery to FDA pipelines.
Career pathing through regular feedback, continuous education, and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching.
Recognition and growth opportunities for strong performance.
At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. The anticipated salary range for candidates in California is provided, with final offers depending on experience, education, and other factors. BridgeBio is a multi-state employer; salary ranges may vary by location.
#J-18808-Ljbffr
- Location:
- Palo Alto, CA
- Salary:
- $200
- Category:
- Marketing, Advertising And PR
We found some similar jobs based on your search
-
4 Days Old
Director/Sr. Director, Health Economics & Outcomes Research Palo Alto, California, United State[...]
-
Palo Alto, CA
-
$200
- Marketing, Advertising And PR
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement… read on. Scroll down the page to see all associated job requirements, and any responsibilities success...
More Details -
-
5 Days Old
Director/Sr. Director, Health Economics & Outcomes Research Palo Alto, California, United State[...]
-
Palo Alto, CA, United States
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement… read on. In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early...
More Details -